B D Jaffee - JoVE Visualize

Showing results (11-20 of 19) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 19 results.

Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998

Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergyD R DeSilva, E A Jones, M F Favata, et al.

Biochemical and Biophysical Research Communications|February 19, 2000

Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivoB D Jaffee, E J Manos, R J Collins, et al.

Osteoarthritis and Cartilage|November 26, 2008

Intra-articular injection of tumor necrosis factor-alpha in the rat: an acute and reversible in vivo model of cartilage proteoglycan degradationA M Malfait, M Tortorella, J Thompson, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

Heteroatom- and carbon-linked biphenyl analogs of Brequinar as immunosuppressive agentsD G Batt, J J Petraitis, S R Sherk, et al.

Nature|November 23, 1995

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IIJ E Dinchuk, B D Car, R J Focht, et al.

Bioorganic & Medicinal Chemistry Letters|May 26, 1999

Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha productionR J Cherney, L Wang, D T Meyer, et al.

Journal of Medicinal Chemistry|October 5, 2001

Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha releaseC B Xue, X He, R L Corbett, et al.

Bioorganic & Medicinal Chemistry Letters|January 1, 1999

Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent Brequinar SodiumW J Pitts, J W Jetter, D J Pinto, et al.

Journal of Medicinal Chemistry|July 27, 2001

Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivoC B Xue, M E Voss, D J Nelson, et al.

Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 19 results.

Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998

Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergyD R DeSilva, E A Jones, M F Favata, et al.

Biochemical and Biophysical Research Communications|February 19, 2000

Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivoB D Jaffee, E J Manos, R J Collins, et al.

Osteoarthritis and Cartilage|November 26, 2008

Intra-articular injection of tumor necrosis factor-alpha in the rat: an acute and reversible in vivo model of cartilage proteoglycan degradationA M Malfait, M Tortorella, J Thompson, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

Heteroatom- and carbon-linked biphenyl analogs of Brequinar as immunosuppressive agentsD G Batt, J J Petraitis, S R Sherk, et al.

Nature|November 23, 1995

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IIJ E Dinchuk, B D Car, R J Focht, et al.

Bioorganic & Medicinal Chemistry Letters|May 26, 1999

Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha productionR J Cherney, L Wang, D T Meyer, et al.

Journal of Medicinal Chemistry|October 5, 2001

Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha releaseC B Xue, X He, R L Corbett, et al.

Bioorganic & Medicinal Chemistry Letters|January 1, 1999

Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent Brequinar SodiumW J Pitts, J W Jetter, D J Pinto, et al.

Journal of Medicinal Chemistry|July 27, 2001

Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivoC B Xue, M E Voss, D J Nelson, et al.

Pageof 2